Home/Filings/4/0001179110-16-017031
4//SEC Filing

AMAG PHARMACEUTICALS INC. 4

Accession 0001179110-16-017031

CIK 0000792977operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:08 PM ET

Size

7.0 KB

Accession

0001179110-16-017031

Insider Transaction Report

Form 4
Period: 2016-01-04
Grund Nicholas
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-01-04+45,00045,000 total
    Exercise: $28.58Exp: 2026-01-04Common Stock (45,000 underlying)
  • Award

    Common Stock

    2016-01-04+32,00032,000 total
Footnotes (3)
  • [F1]These shares of common stock are issuable pursuant to a grant of restricted stock units that vests in three equal annual installments commencing on January 4, 2017. Each restricted stock unit represents a contingent right to receive one share of AMAG Pharmaceuticals, Inc. common stock.
  • [F2]Not applicable.
  • [F3]This option vests and becomes exercisable in four equal annual installments commencing January 4, 2017.

Issuer

AMAG PHARMACEUTICALS INC.

CIK 0000792977

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000792977

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:08 PM ET
Size
7.0 KB